Certified Diabetes Educator Practice Exam 2026 - Free Practice Questions and Study Resource.

The recommended initial pharmacological treatment for a person with diabetes (PWD) who has a blood pressure greater than 140/90 mmHg involves the use of ACE inhibitors or angiotensin receptor blockers (ARBs). This recommendation is based on robust evidence highlighting the cardiovascular benefits and renal protective effects of these medications in individuals with diabetes.

ACE inhibitors and ARBs are particularly effective in managing hypertension in people with diabetes due to their ability to provide renal protection. They help to reduce the progression of diabetic nephropathy, a common complication associated with diabetes. Additionally, these medications lower blood pressure by acting on the renin-angiotensin-aldosterone system, leading to vasodilation and improved blood flow. They also have a favorable effect on cardiovascular events, which is crucial given the elevated risks faced by those living with diabetes.

In contrast, while other classes of antihypertensive medications may also be effective, they do not possess the same degree of renal protection or proven cardiovascular benefits specifically in diabetic populations. Thus, ACE inhibitors and ARBs are advocated as the first-line choice when initiating treatment for hypertension in patients with diabetes, ensuring optimal management of both blood pressure and potential diabetes-related complications.